Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for APOMORPHINE HYDROCHLORIDE
- Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes
- Sublingual Apomorphine in Refractory Restless Legs Syndrome
- Apomorphine in Severe Brain-injured Patients
- Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease
- Apomorphine Effects on Pain in Parkinson's Disease
- Dopaminergic restauratIon by intraVEntriculaire Administration
- Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease
- A Trial of tPCS on Parkinson's Disease OFF State
- Staccato Apomorphine Single and Multi Dose PK
- Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French Hospitals
- Treating Severe Brain-injured Patients With Apomorphine
- A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuati
- A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes
- The Effects of Apomorphine on Experimental and Clinical Pain in Patients With Chronic Radicular Pain
- Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease
- Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
- Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients
- Apomorphine in Parkinson's Disease Patients With Visual Hallucinations
- Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
- A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214
- Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
- Infusion of Apomorphine: Long-term Safety Study
- Treatment of Apomorphine-induced Skin Reactions: a Pilot Study
- Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease
- Apomorphine Effects on Experimental Pain
- Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease
- Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease
- Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease
- Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury
- Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
- Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study
- Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
- Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
- Low Dose Apomorphine and Parkinsonism
- Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)
- A Definitive Estrogen Patch Study (ADEPT)
- Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
- Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
- Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
- A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
- Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease
- JP-1730 to Treat Parkinson's Disease
- EMD 128130 for the Treatment of Parkinson's Disease
Clinical trials list
click for details